News | May 14, 2014

OrbusNeich Launches Sapphire II NC Coronary Dilatation Catheter

Balloon catheter engineered to optimize treatment of tight lesions

May 14, 2014 — OrbusNeich announced the launch of the Sapphire II NC coronary dilatation catheter, a non-compliant balloon catheter engineered to cross tight lesions, outside the United States.

Sapphire II NC’s proprietary balloon processing results in an excellent crossing profile for primary and repeated lesion entry. The enhanced distal Z-Tip with advanced laser welding technology results in “zero” transition between the distal leading tip and conventional steerable guidewires. Sapphire II NC is available in a broad range of sizes, from 1.75 mm to 5 mm, with a catheter working length of 140 cm.

Dr. Toshiya Muramatsu of the Saiseikai Yokohama-City Eastern Hospital in Japan said, “Sapphire II NC with its reduced and improved profile performs well not just as a post but also as a pre dilatation balloon. Robustness and good crossability are very desirable features for a non-compliant balloon."

For more information:

Related Content

Cardiovascular Systems Inc. and OrbusNeich Announce FDA Clearance  of Sapphire II Pro 1mm Coronary Balloon
Technology | Balloon Catheter | March 21, 2018
Cardiovascular Systems Inc. (CSI) recently announced that the U.S. Food and Drug Administration (FDA) has granted 510(k...
Cardiovascular Systems Expands Product Portfolio for Peripheral and Coronary Interventions
News | Balloon Catheter | January 24, 2018
Cardiovascular Systems Inc. recently announced two new partnerships broadening the company’s product portfolio. CSI is...
Abbott recalls its NC Balloon catheters
News | Balloon Catheter | May 22, 2017
May 22, 2017 — Abbott Vascular has initiated a voluntary recall of specific lots of three catheters due to 19 reports
Videos | Balloon Catheter | November 16, 2016
A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the Transc
NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016
NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The device received U.S....
NuCryo Vascular, FDA clearance, next-gen, PolarCath System, cryoplasty inflation device
Technology | Balloon Catheter | January 12, 2016
NuCryo Vascular LLC announced that they have received U.S. Food and Drug Administration (FDA) 510(k) clearance on the...
Videos | Balloon Catheter | October 30, 2015
Todd Brinton, M.D., clinical associate professor and consulting associate professor of bioengineering at Stanford Uni
Overlay Init